FDA Chief Concerned About Fake Weight Loss Drugs FDA Commissioner raises alarm on fake weight loss drugs, warns consumers to be cautious and buy from reputable sources. Top News · Feb 28, 2024
Family Dollar ordered to pay over $40m for rodent-infested Arkansas warehouse Company pleads guilty to using distribution center where FDA discovered ‘decaying rodents, rodent feces, urine, and odors’ The Guardian - US · Feb 28, 2024
Know What's In Your Tattoo Ink: Study Says Over 80% Contain Mislabeled Ingredients Researchers say that more than 80% of tattoo inks they examined in the U.S. contain mislabeled ingredients that could pose potential health risks. Medical Daily · Feb 28, 2024
FDA Warns Of Potential Risk From Hologic Soft Tissue Devices FDA warns of complications with Hologic's soft tissue medical devices, urging vigilance and reporting. Top News · Feb 27, 2024
FDA approves new drug for food allergies "We've literally overnight doubled the amount of options we have to manage this disease" Salon · Feb 27, 2024
Black Americans need tobacco substitutes The decades-long failure to curb cigarette addiction reveals a painful legacy of deception towards Black Americans Salon · Feb 27, 2024
3 Pharma Stocks to Anchor Your Portfolio The pharma market is poised to thrive due to the continuous medicinal advancements to meet the escalating demand for chronic disease treatment, technological advancements, and increased research and development. Given this backdrop, quality pharma stocks Procaps Group S.A. (PROC), Supernus Pharmaceuticals (SUPN), and GSK plc (GSK) could be wise portfolio… StockNews.com · Feb 27, 2024
Beware smartwatches that claim to monitor blood sugar without skin prick, FDA says The Food and Drug Administration has warned consumers against using "smart" devices that are marketed to measure blood sugar without piercing the skin. LiveScience · Feb 27, 2024
DEA Shuts Down Drug Factory Even as Adderall Shortage Persists The DEA is cracking down on manufacturers, hurting patients who genuinely need those drugs. Reason · Feb 26, 2024
Jumpstart Your Portfolio With These 3 Biotech Stocks The biotech industry’s robust growth potential is fueled by scientific advancements, rapid technological adoption, and supportive government initiatives. Thus, you could consider investing in top biotech stocks Exelixis (EXEL), Vertex Pharmaceuticals (VRTX), and Vanda Pharmaceuticals (VNDA) to strengthen your portfolio. Keep reading…. StockNews.com · Feb 26, 2024
This Could Be the Next Blockbuster Drug Stock to Buy Vertex Pharmaceuticals just released data from its experimental drug to relieve pain, with no risk of addiction and very few side effects. This opioid alternative could give Vertex - already a powerhouse in the cystic fibrosis segment - another blockbuster drug to add to its portfolio. Barchart · Feb 23, 2024
Trump's quiet federal abortion ban plot Trump "likes the idea of a 16-week national abortion ban" but wants to keep it quiet, NY Times reports Salon · Feb 23, 2024
Experimental Brain Implant Shows Promise In Treating Depression Learn about Deep Brain Stimulation (DBS) implant for depression treatment, offering hope and relief for patients like Emily Hollenbeck. Top News · Feb 23, 2024
3 Mega-Cap Stocks That Could Replace Tesla in the 'Magnificent Seven' As Tesla stock continues to underperform - now down more than 22% year-to-date - here are 3 mega-cap companies worthy of replacing the beleaguered EV giant in the elite group of mega-cap stocks known as the Magnificent Seven. Barchart · Feb 22, 2024
Top News · Feb 21, 2024 FDA Warns Against Using Smartwatches For Blood Glucose Monitoring FDA warns consumers about potential health risks of using smartwatches for blood glucose monitoring. Stay informed for accurate diabetes management.
LiveScience · Feb 20, 2024 FDA approves 1st-of-its-kind treatment for severe food allergies The FDA has approved the first drug that can reduce the severity of multiple food allergies at once.
Reason · Feb 20, 2024 Supreme Court Denies Red State Effort to Intervene in Mifepristone Case The Court also rejects a late-filed amicus briefs from the American Bar Association, but accepts one from former FDA Commissioners.
LiveScience · Feb 20, 2024 1st frostbite drug approved by FDA after successful clinical trial A drug called Aurlumyn has been approved to treat severe frostbite in the U.S. after a successful clinical trial.
LiveScience · Feb 19, 2024 Elon Musk's Neuralink has concerning lack of transparency and could be vulnerable to hacking, ethicists warn Brain-computer interfaces have the potential to transform some people's lives, but they raise a host of ethical issues, too.
Medical Daily · Feb 19, 2024 FDA Approves First Drug To Treat Food Allergies: Here's What You Need To Know Xolair, a medication initially designed for asthma, has been approved for treating food allergies to prevent severe reactions.
WEKU · Feb 18, 2024 FDA approves a drug to treat severe food allergies, including milk, eggs and nuts Xolair is considered the first medication approved by the FDA that can help protect against severe allergic reactions brought on by accidental exposure to certain foods.
WEKU · Feb 17, 2024 The CDC investigates a multistate E. coli outbreak linked to raw cheddar cheese Health officials reported 10 cases of E. coli infection, adding that the number of people sick is likely "much higher." Those cases were from California, Colorado, Texas and Utah.
WEKU · Feb 17, 2024 FDA approves first cell therapy to treat aggressive forms of melanoma Amtagvi is intended to help patients with melanoma that cannot be removed with surgery or has spread to other parts of the body.
StockNews.com · Feb 16, 2024 Pharma Stocks Analysis: Grab, Hold, or Sell? Despite economic pressures and intensified competition, government incentives and drug innovations are fueling growth in the pharma sector. So, let us delve into the analysis of leading pharma stocks Bristol-Myers Squibb (BMY), Collegium Pharmaceutical (COLL), Pfizer (PFE), and Vaxcyte (PCVX), assessing whether to Grab, Hold, or Sell the stocks amid…
Advnture · Feb 16, 2024 FDA approves first-ever drug to treat severe frostbite and "prevent lifechanging amputation of fingers or toes" Frostbite is an injury to the skin caused when the skin and its underlying tissues freeze, preventing blood, oxygen and nutrients from reaching the affected areas